spacer
home > pmps > summer 2019 > why automate?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Why Automate?

There are many answers to the question 'why automate?', but the bottom line is: if you donít, you will be left behind. Automation in the pharmaceutical industry affects costs, regulatory compliance, and productivity, so why do we need it?

Data, reproducibility, compliance, and, most importantly, reduction of human error. Can a machine make an error? Of course, itís called a malfunction. Usually, it is the human who programmed the machine that caused it, so maintenance teams can help provide technical support to make sure the automated process is programmed correctly.

Once the system is set, there are fewer chances for deviation. Automation also provides an opportunity for round-the-clock work because machines do not need to take a break. The benefits of back-up cloud data and encryptions also provide secure systems that can be implemented globally without the need to retrain or reprogram your operations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Randice Altschul
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Francine Lane Recipient of 2019 DIA Global Inspire Award

JERSEY CITY Ė March 21, 2019 Ė Francine Lane, TrialScope Vice President of Global Transparency, has received a 2019 Global Inspire Award from the Drug Information Association (DIA). Lane, chair of the DIAís Clinical Trial Disclosure Community, and Robert Paarlberg, past chair, are co-recipients of the Community Engagement Award. The award recognizes DIA community chairs for consistently driving engagement while advancing knowledge and thought leadership within their membership communities.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement